See also this year's filing and all EDGAR filings for this company.
PDF Report 0000906709_2023_NEKTAR_THERAPEUTICS.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000906709, NEKTAR THERAPEUTICS
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 545,968,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 76,501,000 |
2 | PropertyPlantAndEquipmentNet | 32,451,000 |
3 | remainder_Assets | 55,680,000 |
4 | LiabilitiesCurrent | 68,204,000 |
5 | LiabilitiesNoncurrent | 120,380,000 |
6 | remainder_Liabilities | 155,378,000 |
7 | CostOfGoodsAndServicesSold | 21,635,000 |
8 | SellingGeneralAndAdministrativeExpense | 92,333,000 |
9 | ResearchAndDevelopmentExpense | 218,323,000 |
10 | remainder_Expenses | 139,145,000 |
11 | remainder_Revenues | 92,055,000 |
12 | remainder_NetIncome | 11,183,000 |
13 | remainder_ComprehensiveNetIncome | -2,750,000 |
yvar | yval | |
---|---|---|
0 | Assets | 710,600,000 |
1 | Liabilities | 343,962,000 |
2 | Expenses | 471,436,000 |
3 | Revenues | 92,055,000 |
4 | StockholdersEquity | 366,638,000 |
5 | NetIncome | -368,198,000 |
6 | ComprehensiveNetIncome | -369,573,000 |
7 | BaseVar | 815,993,000 |
8 | EconomicCapitalRatio | 0.495 |